Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 16094

1.

Flexible Bionanocomposites from Epoxidised Hemp Seed Oil Thermosetting Resin Reinforced with Halloysite Nanotubes.

Shuttleworth PS, Díez-Pascual AM, Marco C, Ellis G.

J Phys Chem B. 2017 Feb 27. doi: 10.1021/acs.jpcb.7b00103. [Epub ahead of print]

PMID:
28240903
2.

Analysis of Drugs of Abuse in Cerumen - Correlation of Postmortem Analysis Results with Those for Blood, Urine and Hair.

Meier SI, Koelzer SC, Schubert-Zsilavecz M, Toennes SW.

Drug Test Anal. 2017 Feb 27. doi: 10.1002/dta.2177. [Epub ahead of print]

PMID:
28240418
3.

Residual Effects of THC via Novel Measures of Brain Perfusion and Metabolism in a Large Group of Chronic Cannabis Users.

Filbey FM, Aslan S, Lu H, Peng SL.

Neuropsychopharmacology. 2017 Feb 27. doi: 10.1038/npp.2017.44. [Epub ahead of print]

PMID:
28240291
4.

The endocannabinoid system modulating levels of consciousness, emotions and likely dream contents.

Murillo-Rodriguez E, Pastrana-Trejo JC, Salas-Crisóstomo M, de-la-Cruz M.

CNS Neurol Disord Drug Targets. 2017 Feb 23. doi: 10.2174/1871527316666170223161908. [Epub ahead of print]

PMID:
28240187
5.

A randomized controlled trial of a brief intervention for alcohol and drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary health care in Chile.

Poblete F, Barticevic NA, Zuzulic MS, Portilla R, Castillo-Carniglia A, Sapag JC, Villarroel L, Sena BF, Galarce M.

Addiction. 2017 Feb 27. doi: 10.1111/add.13808. [Epub ahead of print]

PMID:
28239995
6.

An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use.

Suraev AS, Todd L, Bowen MT, Allsop DJ, McGregor IS, Ireland C, Lintzeris N.

Epilepsy Behav. 2017 Feb 23. pii: S1525-5050(17)30073-2. doi: 10.1016/j.yebeh.2017.02.005. [Epub ahead of print]

PMID:
28238865
7.

Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.

Fond G, Berna F, Andrianarisoa M, Godin O, Leboyer M, Brunel L, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Denizot H, Dubertret C, Dubreucq J, Faget C, Gabayet F, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Richieri R, Rey R, Schandrin A, Urbach M, Vidailhet P, Boyer L, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group..

Eur Arch Psychiatry Clin Neurosci. 2017 Feb 25. doi: 10.1007/s00406-017-0771-4. [Epub ahead of print]

PMID:
28238173
8.

Assessment of tobacco, alcohol and cannabinoid metabolites in 645 meconium samples of newborns compared to maternal self-reports.

Lamy S, Hennart B, Houivet E, Dulaurent S, Delavenne H, Benichou J, Allorge D, Marret S, Thibaut F; Perinatal network of Upper-Normandy..

J Psychiatr Res. 2017 Feb 13;90:86-93. doi: 10.1016/j.jpsychires.2017.02.012. [Epub ahead of print]

PMID:
28237885
9.

Strokes are possible complications of cannabinoids use.

Wolff V, Jouanjus E.

Epilepsy Behav. 2017 Feb 23. pii: S1525-5050(16)30735-1. doi: 10.1016/j.yebeh.2017.01.031. [Epub ahead of print] Review.

PMID:
28237318
10.

[Cannabis-induced disorders].

Soyka M, Preuss U, Hoch E.

Nervenarzt. 2017 Feb 24. doi: 10.1007/s00115-017-0281-7. [Epub ahead of print] German.

PMID:
28236096
11.

Leaner and greener analysis of cannabinoids.

Mudge EM, Murch SJ, Brown PN.

Anal Bioanal Chem. 2017 Feb 23. doi: 10.1007/s00216-017-0256-3. [Epub ahead of print]

PMID:
28233028
12.

Adolescents with cannabis use disorders: Adaptive treatment for poor responders.

Kaminer Y, Ohannessian CM, Burke RH.

Addict Behav. 2017 Feb 16;70:102-106. doi: 10.1016/j.addbeh.2017.02.013. [Epub ahead of print]

PMID:
28232290
13.

Cannabidiol: State of the art and new challenges for therapeutic applications.

Pisanti S, Malfitano AM, Ciaglia E, Lamberti A, Ranieri R, Cuomo G, Abate M, Faggiana G, Proto MC, Fiore D, Laezza C, Bifulco M.

Pharmacol Ther. 2017 Feb 20. pii: S0163-7258(17)30065-7. doi: 10.1016/j.pharmthera.2017.02.041. [Epub ahead of print] Review.

PMID:
28232276
14.

Marijuana and other substance use among male and female underage drinkers who drive after drinking and ride with those who drive after drinking.

Buckley L, Bonar EE, Walton MA, Carter PM, Voloshyna D, Ehrlich PF, Cunningham RM.

Addict Behav. 2017 Feb 10;71:7-11. doi: 10.1016/j.addbeh.2017.02.016. [Epub ahead of print]

PMID:
28231494
15.

Feasibility and acceptability of post-hospitalization ecological momentary assessment in patients with psychotic-spectrum disorders.

Moitra E, Gaudiano BA, Davis CH, Ben-Zeev D.

Compr Psychiatry. 2017 Feb 7;74:204-213. doi: 10.1016/j.comppsych.2017.01.018. [Epub ahead of print]

PMID:
28231480
16.

Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model.

Osborne AL, Solowij N, Babic I, Huang XF, Weston-Green K.

Neuropsychopharmacology. 2017 Feb 23. doi: 10.1038/npp.2017.40. [Epub ahead of print]

PMID:
28230072
17.
18.

Recreational Cannabis - Minimizing the Health Risks from Legalization.

Kilmer B.

N Engl J Med. 2017 Feb 23;376(8):705-707. doi: 10.1056/NEJMp1614783. No abstract available.

PMID:
28225673
19.
20.

Cannabis and Alcohol Use, and the Developing Brain.

Meruelo AD, Castro N, Cota CI, Tapert SF.

Behav Brain Res. 2017 Feb 18. pii: S0166-4328(16)30782-3. doi: 10.1016/j.bbr.2017.02.025. [Epub ahead of print] Review.

PMID:
28223098
Items per page

Supplemental Content

Loading ...
Support Center